Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1973 Mar;7(3):457–460. doi: 10.1128/iai.7.3.457-460.1973

Chlorite-Oxidized Amylose as an Adjuvant for Interferon Production

Hilton B Levy 1,2, Jeff Duenwald 1,2, Charles E Buckler 1,2
PMCID: PMC422699  PMID: 4713694

Abstract

Chlorite-oxidized amylose (COAM), when given intraperitoneally to mice and to cats, increased the titer of serum interferon subsequently induced by polyinosinic·polycytidylic acid (In·Cn). Increases ranged from 6- to 100-fold. Maximal effect was observed when COAM was given 3 h prior to In·Cn. COAM given intravenously prior to Newcastle disease virus also significantly increased serum interferon titers.

Full text

PDF
457

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billiau A., Desmyter J., De Somer P. Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid. J Virol. 1970 Mar;5(3):321–328. doi: 10.1128/jvi.5.3.321-328.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cantor H., Asofsky R., Levy H. B. The effect of polyinosinic-polycytidylic acid upon graft-vs-host activity in BALB/c mice. J Immunol. 1970 Apr;104(4):1035–1038. [PubMed] [Google Scholar]
  3. Claes P., Billiau A., De Clercq E., Desmyter J., Schonne E., Vanderhaeghe H., De Somer P. Polyacetal carboxylic acids: a new group of antiviral polyanions. J Virol. 1970 Mar;5(3):313–320. doi: 10.1128/jvi.5.3.313-320.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Friedman R. M. Effect of interferon treatment on interferon production. J Immunol. 1966 May;96(5):872–877. [PubMed] [Google Scholar]
  5. Glasgow L. A. Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals. J Bacteriol. 1966 Jun;91(6):2185–2191. doi: 10.1128/jb.91.6.2185-2191.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Green J. A., Cooperband S. R., Kibrick S. Immune specific induction of interferon production in cultures of human blood lymphocytes. Science. 1969 Jun 20;164(3886):1415–1417. doi: 10.1126/science.164.3886.1415. [DOI] [PubMed] [Google Scholar]
  7. ISAACS A., BURKE D. C. Mode of action of interferon. Nature. 1958 Oct 18;182(4642):1073–1074. doi: 10.1038/1821073a0. [DOI] [PubMed] [Google Scholar]
  8. Levy H. B., Buckler C. E., Baron S. Effect of interferon on early interferon production. Science. 1966 May 27;152(3726):1274–1276. doi: 10.1126/science.152.3726.1274. [DOI] [PubMed] [Google Scholar]
  9. Levy H. B., Law L. W., Rabson A. S. Inhibition of tumor growth by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A. 1969 Feb;62(2):357–361. doi: 10.1073/pnas.62.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nordlund J. J., Wolff S. M., Levy H. B. Inhibition of biologic activity of poly I: poly C by human plasma. Proc Soc Exp Biol Med. 1970 Feb;133(2):439–444. doi: 10.3181/00379727-133-34492. [DOI] [PubMed] [Google Scholar]
  11. Park J. H., Baron S. Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science. 1968 Nov 15;162(3855):811–813. doi: 10.1126/science.162.3855.811. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES